Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)

导出原文传递

翻译打印收藏纠错

作者： Romero-Laorden, Nuria ^[1] ; Lozano, Rebeca ^[2] ; Jayaram, Anuradha ^[3] ; Lopez-Campos, Fernando ^[4] ; Saez, Maria, I ^[5] ; Montesa, Alvaro ^[6] ; Gutierrez-Pecharoman, Ana ; Villatoro, Rosa ; Herrera, Bernardo ; Correa, Raquel ; Rosero, Adriana ; Pacheco, Maria, I ; Garces, Teresa ; Cendon, Ylenia ; Paz Nombela, Ma ; Van de Poll, Floortje ; Grau, Gala ; Rivera, Leticia ; Lopez, Pedro P. ; Cruz, Juan-Jesus ; Lorente, David ; Attard, Gerhardt ; Castro, Elena ; Olmos, David

作者单位： Hosp Univ Salamanca, Med Oncol Dept, Salamanca, Spain ^[1] Inst Biomed Res Malaga IBIMA, CNIO IBIMA Genitourinary Canc Res Unit, Malaga, Spain ^[2] Hosp Univ La Fe, Med Oncol Dept, Valencia, Spain ^[3] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain ^[4] Inst Canc Res, Ctr Evolut & Canc, Div Mol Pathol, London, England ^[5] Hosp Univ La Princesa, Med Oncol Dept, Madrid, Spain ^[6]

发布时间 2019-04-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

The British journal of cancer

2018年119卷9期

1052-1059页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)

The British journal of cancer

相似文献

The British journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)

The British journal of cancer

相似文献

The British journal of cancer

相关期刊

检索历史清除